Hidemasa Nakaminami
Overview
Explore the profile of Hidemasa Nakaminami including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
117
Citations
595
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Nakaminami H
Biol Pharm Bull
. 2025 Mar;
48(3):196-204.
PMID: 40024689
Recently, the epidemic types of methicillin-resistant Staphylococcus aureus (MRSA) in hospital and community settings in Japan have changed significantly. Before 2010, approximately 80% of the MRSA strains isolated from hospitals...
2.
Watanabe R, Yoshida T, Nakaminami H
Access Microbiol
. 2025 Jan;
7(1.
PMID: 39807476
Antiseptics have been used for infection control against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Ethanol (EtOH) was found to be effective against SARS-CoV-2, while chlorhexidine gluconate (CHG) was less...
3.
Yanai H, Hoshikawa S, Watanabe H, Kaneko H, Nakaminami H, Matsumoto T
Chem Pharm Bull (Tokyo)
. 2024 Oct;
72(10):884-889.
PMID: 39370262
As an easy-to-handle reagent for the in situ generation of outstandingly electrophilic TfC=CH (Tf=CFSO), we have designed and synthesised a novel 4-substituted 2-fluoropyridinium zwitterion, in which a partially fluorinated alkyl...
4.
Tanaka E, Wajima T, Hirano S, Seyama S, Nakaminami H, Uchiya K
J Med Microbiol
. 2024 Oct;
73(10).
PMID: 39360813
Reports of β-lactamase-producing are increasing worldwide.. This study aimed to elucidate the molecular characteristics and evolution of β-lactamase-producing . A total of 159 clinical isolates were characterized using multi-locus sequence...
5.
Tanuma M, Sakurai T, Nakaminami H, Tanaka M
Sci Rep
. 2024 Jun;
14(1):13998.
PMID: 38886220
Recently, the days of antibiotic spectrum coverage (DASC) using the antibiotic spectrum coverage (ASC) score was reported as a new tool for measuring antimicrobial use. The days of therapy (DOT)...
6.
Truong-Bolduc Q, Liao C, Nakaminami H, Strahilevitz J, Leanse L
Front Microbiol
. 2024 Mar;
15:1387518.
PMID: 38486700
No abstract available.
7.
Koizumi J, Nasu Y, Hirai Y, Nakaminami H
Microbiol Resour Announc
. 2024 Mar;
13(4):e0116623.
PMID: 38470265
is a pathogenic bacterium naturally resistant to various antimicrobials, including colistin. Here, we report the whole-genome sequence of , which exhibits high-level multidrug resistance, isolated from a hospitalized patient in...
8.
Hasegawa K, Matsumura Y, Mori T, Asakura T, Nakaminami H
J Infect Chemother
. 2024 Mar;
30(9):887-891.
PMID: 38432558
Objective: Although antimicrobial resistance (AMR) measures have been progressing, cases of patients requesting their doctors to prescribe antimicrobial agents and patients mistakenly believing that these agents are effective against viruses...
9.
Eda H, Arakawa Y, Yoshida T, Ogasawara F, Kojima K, Nakaminami H, et al.
J Infect Chemother
. 2023 Dec;
30(7):651-654.
PMID: 38097041
Community-associated methicillin-resistant Staphylococcus aureus (CA-MRSA) is a global concern, primarily as a cause of skin and soft tissue infections, particularly in young people. Here, we describe a case of unilateral...
10.
Kaneko H, Kanai M, Saito T, Yanagi Y, Kobayashi H, Kurihara R, et al.
Microbiol Spectr
. 2023 Nov;
11(6):e0124823.
PMID: 37929951
USA300 is an MRSA clone producing PVL, a toxin associated with SSTIs. ΨUSA300 is a USA300 variant recently identified in Japan by Takadama et al. (15). Here, we found that...